Heron Therapeutics Inc (HRTX)

Operating Cash Flow Growth

58.77%

TTM · Period ending:

HRTX logo

HRTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported58.77%
HRTX TTM Cash from Operations YoY % (23.53% → 58.77%)
High-resolution chart · PNG

HRTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Heron Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-82,782.66%
-495.1716%
-289.5003%
-588.649%
100.9737%
-226.539%
46.6667%
95.4545%
57.1429%
124%
-69.2308%
36.3636%
-19.0476%
100%
84.3373%
78.4314%
82.2034%
28.2353%
6.7416%
-17.2414%
-38.8235%
1.1628%
-9.8765%
-7.4074%
13.2653%
26.4957%
30.1724%
-2.5316%
-139.0244%
-200%
-286.6667%
-43.6364%
21.1538%
-2.6316%
-3.4483%
-111.5385%
-40.5405%
-11.7647%
25.641%
23.5294%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.